Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus

Rheumatology International

Volumn 16, Issue 3, 1996, Pages 89-94

  Pilkington, C ^a   Taylor, P V ^b   Silverman, E ^c   Isenberg, D A ^a   Costello, A M D L ^d   Rook, G A W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Agalactosyl IgG; Autoimmunity; Neonatal lupus; Ro

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BIRTH; CONGENITAL HEART BLOCK; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; ETIOLOGY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029818004     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01409979     Document Type: Article

References (26)

1. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS (1988) Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. J Rheumatol 27:128-132
2. Alexander E, Buyon JP, Provost TT, Guarnieri T (1992) Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 35:176-189
3. Holmdahl R, Jansson L, Larsson A, Jonsson R (1990) Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol 31: 147-157
4. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth DR, Rademacher TW, Mizuochi T, Taniguchi T, Matsuata K, Takeuchi F, Nagano Y, Miyamoto T, Kobata A (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-457
5. Rademacher T, Parekh RB, Dwek RA, Isenberg D, Rook GAW, Axford JS, Roitt I (1988) The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol 10:231-249
6. Parekh R, Isenberg D, Roitt I, Dwek R, Rademacher T (1988) Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 167:1731-1736
7. Rook GAW, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N, Nelson JL, Bodman KB, Young A, Roitt IM, Williams P, Scragg I, Edge CJ, Arkwright P, Ashford D, Wormald M, Rudd P, Redman C, Dwek RA, Rademacher TW (1991) Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun 4:779-794
8. Thompson SJ, Hitsumoto Y, Zhang YW, Rook GAW, Elson CJ (1992) Agalactosyl IgG in pristane-induced arthritis II. Pregnancy affects the incidence and severity of the arthritis and the galactosylation status of the IgG. Clin Exp Immunol 89:434-438
9. Amino N, Kuro R, Tanizawa O, Tanaka F, Hayashi C, Kotani K, Kawashima M, Miyai K, Kumahara Y (1978) Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin Exp Immunol 31:30-37
10. Rademacher TW (1991) Network theory of glycosylation - aetiologic and pathogenic implication of changes in IgG glycoform levels in autoimmunity. Semin Cell Biol 2:327-337
11. Rook GAW, Stanford JL (1992) Slow bacterial infections or autoimmunity. Immunol Today 13:160-164
12. Rademacher TW, Williams P, Dwek RA (1994) Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci USA 91:6123-6127
13. Rademacher TW, Jones RHV, Williams PJ (1995) Significance and molecular basis for IgG glycosylation changes in rheumatoid arthritis. Adv Exp Med Biol 376:193-204
14. Rook GAW, Steele J, Rademacher T (1988) A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IaG from rheumatoid arthritis. Ann Rheum Dis 47:247-250
15. McCulloch J, Zang YW, Dawson M, Harkiss GD, Peterhans H, Vogt HR, Lydyard PM, Rook GAW (1994) Glycosylation of IgG during potentially arthritogenic lentiviral infections. Rheumatol Int 14:243-248
16. Pilkington C, Lefvert A-K, Rook GAW (1995) Neonatal myasthenia gravis and the role of agalactosyl IgG. Autoimmunilv 21:131-135
17. Williams PJ, Arkwright PD, Rudd P, Scragg IG, Edge CJ, Rademacher TW (1995) Selective placental transport of maternal IgG to the fetus. Placenta 16:749-756
18. Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, Avrameas S (1985) High frequency of natural autoantibodies in normal newborn mice. J Immunol 134:765-771
19. Dighiero G, Lymberi P, Guilbert B, Ternynck T, Avrameas S (1986) Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann NY Acad Sci 475: 135-145
20. Cohen IR, Young DB (1991) Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 12:105-110
21. Lefvert AK, Osterman PO (1983) Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 33:133-138
22. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237-243
23. Rook GAW, Thompson S, Buckley M, Elson C, Brealey R, Lambert C, Whyte A, Rademacher TW (1991) The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol 21:1027-1032
24. Hitsumoto Y, Thompson SJ, Zhang Y, Rook GAW, Elson CJ (1992) Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis. Autoimmunity 11:247-254
25. Young A, Sumar N, Bodman K, Goyal S, Sinclair H, Roitt I, Isenberg D (1991) Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum 34:1425-1429
26. van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld FC (1993) Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 20:1288-1296